Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

BOFA $Eli Lilly and Co (LLY.US)$ full SURMOUNT-OSA results A...

BOFA $Eli Lilly and Co(LLY.US)$ full SURMOUNT-OSA results ADA supporting regulatory approval In patients with moderate-to-severe OSA and obesity, tirzepatide treatment resolved disease in 43-51.5% of patients
impressive magnitude of response, expect LLY shares to trade with strength on Monda
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
19K Views
Comment
Sign in to post a comment
    199Followers
    13Following
    578Visitors
    Follow